Loading…

Adverse effects of COVID-19 vaccines and measures to prevent them

Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated indi...

Full description

Saved in:
Bibliographic Details
Published in:Virology journal 2022-06, Vol.19 (1), p.100-3, Article 100
Main Author: Yamamoto, Kenji
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633
cites cdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633
container_end_page 3
container_issue 1
container_start_page 100
container_title Virology journal
container_volume 19
creator Yamamoto, Kenji
description Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.
doi_str_mv 10.1186/s12985-022-01831-0
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_ace231bca0c94744aa8d5dce326ec5d7</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A706149227</galeid><doaj_id>oai_doaj_org_article_ace231bca0c94744aa8d5dce326ec5d7</doaj_id><sourcerecordid>A706149227</sourcerecordid><originalsourceid>FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</originalsourceid><addsrcrecordid>eNptkl1rFDEUhgdRbK3-AS9kwCsvpub740ZYtlYXCgW_8C5kkpPtLDuTNZlZ9N832621A5KLJOe85-Gcw1tVrzE6x1iJ9xkTrXiDCGkQVhQ36El1iiWjDSPk59NH75PqRc4bhCgRUj-vTigXXAslT6vFwu8hZaghBHBjrmOol9c_VhcN1vXeOtcNkGs7-LoHm6dUPmOsdwn2MIz1eAP9y-pZsNsMr-7vs-r75cdvy8_N1fWn1XJx1ThO5NgQ66WUFpD3LThwrVdEstYJJEgg3NPAFUgSPNGcEihCppzgiuk2eCooPatWR66PdmN2qett-mOi7cxdIKa1sWns3BaMdUAobp1FTjPJmLXKc--gjA-Oe1lYH46s3dT2UDLDmOx2Bp1nhu7GrOPeaCzKTnEBvL0HpPhrgjyaTZzSUOY3ZcWKYCY1-qda29JVN4RYYK7vsjMLiQRmmpBDM-f_UZXjoe9cHCB0JT4reDcrKJoRfo9rO-VsVl-_zLXkqHUp5pwgPAyJkTm4yBxdZIqLzJ2LzKHvN4_X81Dy1zb0FvmRwJk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2678214790</pqid></control><display><type>article</type><title>Adverse effects of COVID-19 vaccines and measures to prevent them</title><source>Publicly Available Content Database</source><source>PubMed Central</source><source>Coronavirus Research Database</source><creator>Yamamoto, Kenji</creator><creatorcontrib>Yamamoto, Kenji</creatorcontrib><description>Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.</description><identifier>ISSN: 1743-422X</identifier><identifier>EISSN: 1743-422X</identifier><identifier>DOI: 10.1186/s12985-022-01831-0</identifier><identifier>PMID: 35659687</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Acetaminophen ; Acquired immune deficiency syndrome ; AIDS ; Antibiotics ; Antibodies ; Body temperature ; Cigarette smoking ; Comment ; Coronaviruses ; COVID-19 ; COVID-19 vaccines ; Critically ill patients ; Disease prevention ; Drug addiction ; Drug dosages ; Herpes zoster ; Host-virus relationships ; Immune response ; Immunosuppression ; Immunosuppressive agents ; Infections ; Inflammation ; Lipids ; mRNA vaccines ; Nanoparticles ; Nonsteroidal anti-inflammatory drugs ; Observations ; Older people ; Pandemics ; Patients ; Propofol ; Proteins ; Risk factor ; Risk factors ; Severe acute respiratory syndrome coronavirus 2 ; Spike protein ; Surgery ; Thrombocytopenia ; Vaccination ; Vaccine-acquired immunodeficiency syndrome ; Vaccines</subject><ispartof>Virology journal, 2022-06, Vol.19 (1), p.100-3, Article 100</ispartof><rights>2022. The Author(s).</rights><rights>COPYRIGHT 2022 BioMed Central Ltd.</rights><rights>2022. This work is licensed under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</citedby><cites>FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9167431/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2678214790?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,38516,43895,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35659687$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Kenji</creatorcontrib><title>Adverse effects of COVID-19 vaccines and measures to prevent them</title><title>Virology journal</title><addtitle>Virol J</addtitle><description>Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.</description><subject>Acetaminophen</subject><subject>Acquired immune deficiency syndrome</subject><subject>AIDS</subject><subject>Antibiotics</subject><subject>Antibodies</subject><subject>Body temperature</subject><subject>Cigarette smoking</subject><subject>Comment</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>COVID-19 vaccines</subject><subject>Critically ill patients</subject><subject>Disease prevention</subject><subject>Drug addiction</subject><subject>Drug dosages</subject><subject>Herpes zoster</subject><subject>Host-virus relationships</subject><subject>Immune response</subject><subject>Immunosuppression</subject><subject>Immunosuppressive agents</subject><subject>Infections</subject><subject>Inflammation</subject><subject>Lipids</subject><subject>mRNA vaccines</subject><subject>Nanoparticles</subject><subject>Nonsteroidal anti-inflammatory drugs</subject><subject>Observations</subject><subject>Older people</subject><subject>Pandemics</subject><subject>Patients</subject><subject>Propofol</subject><subject>Proteins</subject><subject>Risk factor</subject><subject>Risk factors</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Spike protein</subject><subject>Surgery</subject><subject>Thrombocytopenia</subject><subject>Vaccination</subject><subject>Vaccine-acquired immunodeficiency syndrome</subject><subject>Vaccines</subject><issn>1743-422X</issn><issn>1743-422X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkl1rFDEUhgdRbK3-AS9kwCsvpub740ZYtlYXCgW_8C5kkpPtLDuTNZlZ9N832621A5KLJOe85-Gcw1tVrzE6x1iJ9xkTrXiDCGkQVhQ36El1iiWjDSPk59NH75PqRc4bhCgRUj-vTigXXAslT6vFwu8hZaghBHBjrmOol9c_VhcN1vXeOtcNkGs7-LoHm6dUPmOsdwn2MIz1eAP9y-pZsNsMr-7vs-r75cdvy8_N1fWn1XJx1ThO5NgQ66WUFpD3LThwrVdEstYJJEgg3NPAFUgSPNGcEihCppzgiuk2eCooPatWR66PdmN2qett-mOi7cxdIKa1sWns3BaMdUAobp1FTjPJmLXKc--gjA-Oe1lYH46s3dT2UDLDmOx2Bp1nhu7GrOPeaCzKTnEBvL0HpPhrgjyaTZzSUOY3ZcWKYCY1-qda29JVN4RYYK7vsjMLiQRmmpBDM-f_UZXjoe9cHCB0JT4reDcrKJoRfo9rO-VsVl-_zLXkqHUp5pwgPAyJkTm4yBxdZIqLzJ2LzKHvN4_X81Dy1zb0FvmRwJk</recordid><startdate>20220605</startdate><enddate>20220605</enddate><creator>Yamamoto, Kenji</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>3V.</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20220605</creationdate><title>Adverse effects of COVID-19 vaccines and measures to prevent them</title><author>Yamamoto, Kenji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Acetaminophen</topic><topic>Acquired immune deficiency syndrome</topic><topic>AIDS</topic><topic>Antibiotics</topic><topic>Antibodies</topic><topic>Body temperature</topic><topic>Cigarette smoking</topic><topic>Comment</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>COVID-19 vaccines</topic><topic>Critically ill patients</topic><topic>Disease prevention</topic><topic>Drug addiction</topic><topic>Drug dosages</topic><topic>Herpes zoster</topic><topic>Host-virus relationships</topic><topic>Immune response</topic><topic>Immunosuppression</topic><topic>Immunosuppressive agents</topic><topic>Infections</topic><topic>Inflammation</topic><topic>Lipids</topic><topic>mRNA vaccines</topic><topic>Nanoparticles</topic><topic>Nonsteroidal anti-inflammatory drugs</topic><topic>Observations</topic><topic>Older people</topic><topic>Pandemics</topic><topic>Patients</topic><topic>Propofol</topic><topic>Proteins</topic><topic>Risk factor</topic><topic>Risk factors</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Spike protein</topic><topic>Surgery</topic><topic>Thrombocytopenia</topic><topic>Vaccination</topic><topic>Vaccine-acquired immunodeficiency syndrome</topic><topic>Vaccines</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Kenji</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Databases</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Virology journal</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Kenji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Adverse effects of COVID-19 vaccines and measures to prevent them</atitle><jtitle>Virology journal</jtitle><addtitle>Virol J</addtitle><date>2022-06-05</date><risdate>2022</risdate><volume>19</volume><issue>1</issue><spage>100</spage><epage>3</epage><pages>100-3</pages><artnum>100</artnum><issn>1743-422X</issn><eissn>1743-422X</eissn><abstract>Recently, The Lancet published a study on the effectiveness of COVID-19 vaccines and the waning of immunity with time. The study showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals. According to European Medicines Agency recommendations, frequent COVID-19 booster shots could adversely affect the immune response and may not be feasible. The decrease in immunity can be caused by several factors such as N1-methylpseudouridine, the spike protein, lipid nanoparticles, antibody-dependent enhancement, and the original antigenic stimulus. These clinical alterations may explain the association reported between COVID-19 vaccination and shingles. As a safety measure, further booster vaccinations should be discontinued. In addition, the date of vaccination should be recorded in the medical record of patients. Several practical measures to prevent a decrease in immunity have been reported. These include limiting the use of non-steroidal anti-inflammatory drugs, including acetaminophen to maintain deep body temperature, appropriate use of antibiotics, smoking cessation, stress control, and limiting the use of lipid emulsions, including propofol, which may cause perioperative immunosuppression. In conclusion, COVID-19 vaccination is a major risk factor for infections in critically ill patients.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>35659687</pmid><doi>10.1186/s12985-022-01831-0</doi><tpages>3</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1743-422X
ispartof Virology journal, 2022-06, Vol.19 (1), p.100-3, Article 100
issn 1743-422X
1743-422X
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_ace231bca0c94744aa8d5dce326ec5d7
source Publicly Available Content Database; PubMed Central; Coronavirus Research Database
subjects Acetaminophen
Acquired immune deficiency syndrome
AIDS
Antibiotics
Antibodies
Body temperature
Cigarette smoking
Comment
Coronaviruses
COVID-19
COVID-19 vaccines
Critically ill patients
Disease prevention
Drug addiction
Drug dosages
Herpes zoster
Host-virus relationships
Immune response
Immunosuppression
Immunosuppressive agents
Infections
Inflammation
Lipids
mRNA vaccines
Nanoparticles
Nonsteroidal anti-inflammatory drugs
Observations
Older people
Pandemics
Patients
Propofol
Proteins
Risk factor
Risk factors
Severe acute respiratory syndrome coronavirus 2
Spike protein
Surgery
Thrombocytopenia
Vaccination
Vaccine-acquired immunodeficiency syndrome
Vaccines
title Adverse effects of COVID-19 vaccines and measures to prevent them
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T17%3A41%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Adverse%20effects%20of%20COVID-19%20vaccines%20and%20measures%20to%20prevent%20them&rft.jtitle=Virology%20journal&rft.au=Yamamoto,%20Kenji&rft.date=2022-06-05&rft.volume=19&rft.issue=1&rft.spage=100&rft.epage=3&rft.pages=100-3&rft.artnum=100&rft.issn=1743-422X&rft.eissn=1743-422X&rft_id=info:doi/10.1186/s12985-022-01831-0&rft_dat=%3Cgale_doaj_%3EA706149227%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c527t-2ad777ae0ddbececbd8274bc6062f25d3f58e72fd29532eae048c65849bfd3633%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2678214790&rft_id=info:pmid/35659687&rft_galeid=A706149227&rfr_iscdi=true